aflibercept vs prednisolone ophthalmic
Side-by-side comparison of aflibercept and prednisolone ophthalmic Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Eylea
Pred Forte
AHZANTIVE is a medicine used to treat certain eye problems. It helps to stop blood vessels from growing and leaking in the eye.
Pred Forte is an eye drop medicine that helps reduce swelling and redness in your eye. It belongs to a class of drugs called corticosteroids.
AHZANTIVE treats wet age-related macular degeneration (AMD). It also treats swelling in the macula (the central part of the retina) caused by retinal vein occlusion (RVO) or diabetic macular edema (DME). Additionally, it can treat diabetic retinopathy (DR), an eye disease caused by diabetes.
Pred Forte treats swelling and inflammation in your eye. It can help with conditions affecting the conjunctiva (the clear covering of your eye), cornea, and the front part of your eye. This medicine works to relieve redness, itching, and pain in these areas.
AHZANTIVE is a VEGF inhibitor. VEGF is a protein that promotes the growth of new blood vessels. By blocking VEGF, AHZANTIVE helps to reduce the growth of abnormal blood vessels in the eye and decrease leakage.
Pred Forte contains prednisolone acetate, which is a type of corticosteroid. Corticosteroids reduce inflammation by blocking the substances in the body that cause it. This helps to relieve symptoms like redness and swelling in the eye.
- • Bleeding in the eye
- • Eye pain
- • Clouding of the lens of the eye (cataract)
- • Separation of the vitreous gel from the retina
- • Spots in your vision
- • Eye pain
- • Feeling like something is in your eye
- • Headache
- • Itching
- • Rash
- Death 7,853
- Trouble seeing 2,013
- Using the medicine for something it's not approved for 1,509
- Loss of sight 1,459
- Eye infection 1,372
No adverse event reports.
Injections with AHZANTIVE may cause serious eye infections (endophthalmitis), separation of the retina (retinal detachment), and inflammation of blood vessels in the retina. Tell your doctor right away if you have any signs of these problems. AHZANTIVE may also increase the risk of blood clots that can cause stroke or heart attack.
You should not take Pred Forte if you have certain types of eye infections. These include untreated bacterial infections, most viral infections of the cornea or conjunctiva (like herpes simplex), fungal infections, or tuberculosis of the eye. Also, do not use it if you are allergic to any of its ingredients or other corticosteroids.
It is not known if AHZANTIVE can harm an unborn baby. AHZANTIVE should be used during pregnancy only if the benefit justifies the risk. It is also not known if AHZANTIVE passes into breast milk.
Tell your doctor if you are pregnant or breastfeeding before using Pred Forte. It is not known if this medicine will harm an unborn baby or pass into breast milk.
Also Compare — Nearby Drugs
Compare aflibercept with
Compare prednisolone ophthalmic with
How to Read This aflibercept vs prednisolone ophthalmic Comparison
aflibercept is classified in the Anti-VEGF (Ophthalmic Injection) drug class, while prednisolone ophthalmic sits within the Corticosteroid (Ophthalmic) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, aflibercept has 14,206 submissions while prednisolone ophthalmic has 0. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between aflibercept and prednisolone ophthalmic — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.